BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants John Bluth - SVP, IR and Corporate Communications Jon Stonehouse - Chief Executive Officer Anthony Doyle - Chief Financial Officer Charlie Gayer - Chief Commercial Officer Helen Thackray - Chief R&D Officer Conference Call Participants Ken Cacciatore - Cowen and Company Chris Raymond - Piper Sandler Daniel Wolle - JPMorgan Joe Spak - RBC Capital Jon Wolleben - JMP Securities Gena Wa ...